Published in Vaccine on January 31, 2002
Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62
Whooping cough--a continuing problem. BMJ (2002) 1.43
Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants. Epidemiol Infect (2006) 1.06
Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. PLoS One (2010) 0.98
Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Natl Acad Sci U S A (2015) 0.88
Individual and community level determinants of childhood full immunization in Ethiopia: a multilevel analysis. BMC Public Health (2015) 0.82
A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents. Can J Infect Dis Med Microbiol (2005) 0.81
A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Epidemiol Infect (2005) 0.80
The distribution over time of costs and social net benefits for pertussis immunization programs. Int J Health Care Finance Econ (2009) 0.75
Delaying the international spread of pandemic influenza. PLoS Med (2006) 4.50
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis. J Natl Cancer Inst (2012) 3.87
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2012) 3.25
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis (2005) 2.29
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine (2007) 2.01
Using time-use data to parameterize models for the spread of close-contact infectious diseases. Am J Epidemiol (2008) 1.92
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ (2010) 1.88
Modeling cervical cancer prevention in developed countries. Vaccine (2008) 1.61
Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination. J Natl Cancer Inst (2013) 1.60
Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London. Proc Natl Acad Sci U S A (2011) 1.58
An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia. Can J Urol (2004) 1.56
Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol (2005) 1.52
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis (2010) 1.41
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5. Value Health (2012) 1.38
Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. Am J Epidemiol (2007) 1.38
Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc Biol Sci (2011) 1.28
Estimating deaths due to influenza and respiratory syncytial virus. JAMA (2003) 1.23
A prospective study of the herpes zoster severity of illness. Clin J Pain (2010) 1.22
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine (2011) 1.21
Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis. Vaccine (2010) 1.18
7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? PLoS One (2011) 1.16
Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics (2011) 1.14
Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Sex Transm Dis (2009) 1.10
Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004. J Infect Dis (2005) 1.08
Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination. Cancer Causes Control (2009) 1.07
Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine (2012) 1.05
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom. Vaccine (2011) 1.01
Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One (2013) 1.00
Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts. BMC Med (2013) 1.00
Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain (2010) 0.99
Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health (2005) 0.97
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5. Med Decis Making (2012) 0.97
Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination. Cancer Epidemiol Biomarkers Prev (2013) 0.97
Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine. Int J Cancer (2013) 0.95
Deaths from chickenpox. Deaths from chickenpox in adults are decreasing. BMJ (2002) 0.95
The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sex Transm Dis (2011) 0.94
Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol (2010) 0.93
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide. Med Decis Making (2011) 0.93
The psychosocial impact of an abnormal cervical smear result. Psychooncology (2011) 0.92
Can reactive school closures help critical care provision during the current influenza pandemic? PLoS Curr (2009) 0.90
Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia. Clin Infect Dis (2007) 0.89
Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings. BMC Med (2015) 0.88
Vaccination against herpes zoster in developed countries: state of the evidence. Hum Vaccin Immunother (2013) 0.87
Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study. Can J Infect Dis Med Microbiol (2008) 0.86
Varicella vaccine and shingles. JAMA (2002) 0.85
Loss of quality of life associated with genital warts: baseline analyses from a prospective study. Sex Transm Infect (2011) 0.85
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools. BMC Med (2011) 0.85
Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy. Vaccine (2013) 0.84
The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysis. Vaccine (2013) 0.83
A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophy. Pharmacoeconomics (2006) 0.80
Proceedings of the Modeling Evidence in HPV Pre-Conference Workshop in Malmö, Sweden, May 9-10, 2009. Clin Ther (2010) 0.80
Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness? PLoS One (2013) 0.79
Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland. Vaccine (2003) 0.78
Prevalence and Frequency of Heterosexual Anal Intercourse Among Young People: A Systematic Review and Meta-analysis. AIDS Behav (2015) 0.78
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerg Infect Dis (2016) 0.78
Response. J Natl Cancer Inst (2013) 0.77
Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system. Value Health (2013) 0.77
Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources. Eur J Pain (2011) 0.77
The Manitoba human papillomavirus vaccine surveillance and evaluation system. Health Rep (2010) 0.76
Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior. Emerg Infect Dis (2016) 0.75
Bias Due to Correlation Between Times-at-Risk for Infection in Epidemiologic Studies Measuring Biological Interactions Between Sexually Transmitted Infections: A Case Study Using Human Papillomavirus Type Interactions. Am J Epidemiol (2016) 0.75
Response. J Natl Cancer Inst (2013) 0.75